Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: J Radiother Pract. 2017 May 8;16(2):148–154. doi: 10.1017/S1460396917000061

Table 2.

Characteristics of patients with grade 3+ toxicity

No. Gender Tumour type Location Tumour size (cm) Total dose/fx (Gy/Fx) History Follow-up (months) Toxicity grade Toxicity Time to toxicity (months)
1 M Mets LUL 2·7 30/1 SBRT 60 Gy in 3 fx (LLL) 41·2 3 Left vocal cord palsy 14·5
2 M Mets Right hilum 3 26/1 Chemo-radiation (70 Gy in 35 fx, cancer in the base of tongue) 12·8 4 Bronchopulmonary haemorrhage 12·6
3 F NSCLC LUL 1·6 52·5/5 Surgery (RUL) 33·7 3 Pulmonary embolism 19·1
4 M NSCLC RML 2·3 55/5 Surgery (LUL) 22·9 3 Pleural effusion 14·6

Abbreviations: Fx, fraction; M, male; F, female; mets, pulmonary oligometastasis; SBRT, stereotactic body radiation therapy; NSCLC, primary non-small cell lung cancer; LUL, left upper lobe; RML, right middle lobe; LLL, left lower lobe; RUL, right upper lobe.